114 related articles for article (PubMed ID: 15824077)
21. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
22. [Detection of serum Lp(a) level of coronary heart disease and its clinical significance].
Liang XH; Huang CZ
Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):227-8. PubMed ID: 12536688
[TBL] [Abstract][Full Text] [Related]
23. Prediction of first events of coronary heart disease and stroke with consideration of adiposity.
Wilson PW; Bozeman SR; Burton TM; Hoaglin DC; Ben-Joseph R; Pashos CL
Circulation; 2008 Jul; 118(2):124-30. PubMed ID: 18591432
[TBL] [Abstract][Full Text] [Related]
24. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
[TBL] [Abstract][Full Text] [Related]
25. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
26. The influence of physiological and surgical menopause on coronary heart disease risk markers.
Verhoeven MO; van der Mooren MJ; Teerlink T; Verheijen RH; Scheffer PG; Kenemans P
Menopause; 2009; 16(1):37-49. PubMed ID: 18791484
[TBL] [Abstract][Full Text] [Related]
27. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C
Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
[TBL] [Abstract][Full Text] [Related]
28. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk factors in obese women and their first-degree relatives.
Saraç F; Ozgen AG; Yilmaz C; Tüzün M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
[TBL] [Abstract][Full Text] [Related]
30. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
[TBL] [Abstract][Full Text] [Related]
31. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.
Jee SH; Boulware LE; Guallar E; Suh I; Appel LJ; Miller ER
Arch Intern Med; 2005 Oct; 165(19):2299-304. PubMed ID: 16246998
[TBL] [Abstract][Full Text] [Related]
32. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH; Chunawala L; Linde R; Reaven GM
J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
[TBL] [Abstract][Full Text] [Related]
34. Hemoglobin levels and coronary artery disease.
Chonchol M; Nielson C
Am Heart J; 2008 Mar; 155(3):494-8. PubMed ID: 18294483
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.
Shai I; Schulze MB; Manson JE; Stampfer MJ; Rifai N; Hu FB
Diabetologia; 2005 Aug; 48(8):1469-76. PubMed ID: 15971061
[TBL] [Abstract][Full Text] [Related]
36. Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study.
De Sutter J; De Bacquer D; Cuypers S; Delanghe J; De Buyzere M; Kornitzer M; De Backer G
Eur Heart J; 2005 Dec; 26(24):2644-9. PubMed ID: 16204267
[TBL] [Abstract][Full Text] [Related]
37. Adiponectin and coronary heart disease: a prospective study and meta-analysis.
Sattar N; Wannamethee G; Sarwar N; Tchernova J; Cherry L; Wallace AM; Danesh J; Whincup PH
Circulation; 2006 Aug; 114(7):623-9. PubMed ID: 16894037
[TBL] [Abstract][Full Text] [Related]
38. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
[TBL] [Abstract][Full Text] [Related]
39. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
Rothenbacher D; Koenig W; Brenner H
Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
[TBL] [Abstract][Full Text] [Related]
40. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
Cantin B; Després JP; Lamarche B; Moorjani S; Lupien PJ; Bogaty P; Bergeron J; Dagenais GR
Am J Cardiol; 2002 Mar; 89(6):662-6. PubMed ID: 11897206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
